LSI USA

At LSI USA ’25, the question wasn’t whether soft tissue robotics will reshape surgery, but how. In a panel titled Soft Tissue Robotics: Open Architecture or Closed System? The Road Forward , industry leaders tackled one of the field’s most urgent debates: whether future surgical platforms should embrace openness or remain tightly integrated. Moderated by Joe Mullings of The Mullings Group, the conversation spanned technical ecosystems, innovation bottlenecks, surgeon preferences, and investment models. The verdict? There’s no single answer, but the stakes for patients, startups, and strategics have never been higher. Defining the Debate in Soft Tissue Robotics To level-set the discussion, Mullings began by asking the panelists to define what “open” and “closed” mean in the context of soft tissue robotics. Greg Roche, CEO of Distalmotion, put it simply: “Choice is the difference between open and closed. When you close something down, you limit the offering in the long term.” Roche a...

01 Where can I register for LSI USA ‘26? Register for LSI USA ’26 here . You can also apply to present at LSI USA ’26 here . 02 What does my LSI USA ’26 registration include? Registration includes access to all days of the event (March 16–20), all sessions, meals, networking receptions, and the partnering platform. 03 Will meals be provided during the event? Yes. Breakfast, lunch, and dinner will be served on March 17, March 18, and March 19, with an additional dinner served on March 16 during the Welcome Reception. 04 Can I register a group of people for LSI USA ‘26? Yes. Please contact kelly@ls-intel.com for more details. 05 Can I get a discount for registering for multiple LSI events? Please contact kelly@ls-intel.com for more details. 06 I’m a very early-stage startup. Is it too soon for me to attend or present at LSI USA ‘26? Not at all. LSI features startups ranging from pre-seed to Series D and beyond, alongside early-stage investors, growth-stage VCs, and strategics. It’s never...

General FAQs 01 When and where will LSI USA ’26 be held? LSI USA ’26 takes place March 16–20, 2026, at the Waldorf Astoria Monarch Beach Resort in Dana Point, California. Secure your accommodations early as exclusive hotel rates are available while supplies last. Book hotel here 02 Who attends LSI USA ‘26? 1800+ medtech and healthtech founders, startups, investors, strategics, and service providers attend LSI events each year. Registration FAQs 01 Where can I register for LSI USA ‘26? Register for LSI USA ’26 here . You can also apply to present at LSI USA ’26 here . 02 What does my LSI USA ’26 registration include? Registration includes access to all days of the event (March 16–20), all sessions, meals, networking receptions, and the partnering platform. 03 Will meals be provided during the event? Yes. Breakfast, lunch, and dinner will be served on March 17, March 18, and March 19, with an additional dinner served on March 16 during the Welcome Reception. 04 Can I register a group of ...

Timing emerged as one of the biggest threats to the success of build-to-buy models. Ramin Mousavi likened the model to a long engagement. “You enter into an agreement where the wedding is down the road. But the more you get to know each other, the more you find things you don’t like,” he said. “And the more successful you are, the worse it feels, because in an open market, you’d likely get a better deal.” Makower was candid: “I don’t know many build-to-buys that have actually consummated in the end.” For more details read here:  https://www.slideserve.com/James1267/why-the-clock-kills-more-deals-than-the-competition

Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels. The desire to innovate and create positive change has always been a priority for the founders and inventors, Dr. John Wong and Dr. Alim Mitha. For more information watch this video:  https://www.lifesciencemarketresearch.com/videos/john-wong-fluid-biomed-studio-interview-lsi-usa-25

 Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid’s CTA analysis equips physicians with critical information designed to enable precision medicine. For more information watch this video: https://www.lifesciencemarketresearch.com/videos/kelly-huang-elucid-studio-interview-lsi-usa-25